Processing of your personal data

This website might use cookies or other personal data for the purposes of the functioning of the website. Some of these cookies are mandatory, while the other ones only help us to improve your browsing experience and get information on how the website is used.

Privacy message

All news

Filter by:
charts-graphs-with-magnifying-glass-pencil-calculator-clock-reflection-light-flare-concept-image-data-gathering-statistical-working.jpg
LITHUANIAN COMPETITION AUTHORITY IDENTIFIES FOUR PRIORITY SECTORS
11 01 2022

In the strategic plan 2022 the Lithuanian Konkurencijos taryba has identified four priority sectors. The authority is planning to monitor more closely competition restrictions in the labour market, health sector (including pharmaceuticals), retail trade and e-commerce, as well as to take active enforcement and advocacy actions.

IN 2016 ONE EURO INVESTED IN COMPETITION COUNCIL BROUGHT ALMOST 8 EUROS IN RETURN
14 06 2017

On June 14 the Chairman Šarūnas Keserauskas presented the Competition Council‘s annual report to the members of the Cabinet.

vaistai.png
FINAL CONCLUSIONS OF MARKET STUDY ON REIMBURSABLE PHARMACEUTICALS
06 12 2016

On December 5, 2016 the Competition Council confirmed the final conclusions of the market study on reimbursable pharmaceuticals (hereinafter  –  Study) that revealed competition problems in the market, to which possible solutions were proposed.

medications-342466_1920 (640x427).jpg
COMPETITION COUNCIL: ADVERTISING BY CAMELIA MISLED CONSUMERS
06 09 2016

The Competition Council (hereinafter – Council) found that UAB Nemuno vaistinė (hereinafter – Company) made false claims about 30 per cent cheaper products sold in the pharmacies of Camelia (hereinafter – Camelia ), and thus breached Article 5 of the Law on Advertising.

iStock_000076263347_Full.jpg
COMPETITION COUNCIL CALLS FOR OPINIONS REGARDING MARKET STUDY REPORT ON REIMBURSABLE PHARMACEUTICALS
06 06 2016

The Competition Council (hereinafter – KT) has submitted its preliminary market study report on reimbursable pharmaceuticals for public consultation. KT experts aimed at finding out if current legal regulation does not create obstacles for pharmaceuticals to enter the market of reimbursable pharmaceuticals and stay in it, and whether competition...

LITHUANIAN COMPETITION AUTHORITY PROPOSES TO LIBERALISE PHARMACEUTICAL MARKET
17 12 2013

The Lithuanian competition authority conducted a market study on the parallel import of pharmaceuticals. The aim of the study was to assess the situation in the Lithuanian pharmaceutical market and identify the main circumstances determining a low share of the trade of parallel imported pharmaceuticals in Lithuania, as well as to provide proposals on how effective competition could be ensured in the market.

Items
per page
11 out of 11